menu
    • menu

    Company profile for Solaris Pharma

    NEW Drugs in Dev: 2
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solaris Pharma Corporation is a leading specialty dermatology company committed to the identifying, developing and marketing of high-quality, generic and specialty pharmaceutical products. Solaris Pharma Corporation employs an experienced R&D and management team focused on right-first-time development while maintaining the highest quality standards. With a strong financial position and employee centric focus, the company striv...
    Solaris Pharma Corporation is a leading specialty dermatology company committed to the identifying, developing and marketing of high-quality, generic and specialty pharmaceutical products. Solaris Pharma Corporation employs an experienced R&D and management team focused on right-first-time development while maintaining the highest quality standards. With a strong financial position and employee centric focus, the company strives to be a pacesetter in the niche dermatology market. Solaris Pharma Corporation is dedicated to developing a broad portfolio of generic and specialty dermatological products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solaris PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1031 Route 202/206, Suite G-200 New Jersey 08807
    Telephone
    Telephone
    908-800-0300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.solaris-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solaris' Generic Tazarotene Receives Approval in the U.S.
    Solaris' Generic Tazarotene Receives Approval in the U.S.

    20 Mar 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213644

    FDA
    20 Mar 2023
    Share Share
    Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors
    Solaris Biotech and Wildtype Announce Agreement for Large-scale Bioreactors

    15 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115006265/en

    BUSINESSWIRE
    15 Nov 2022
    Share Share
    Solaris Pharma's Generic Clobetasol Propionate Receives Approval in the U.S.
    Solaris Pharma's Generic Clobetasol Propionate Receives Approval in the U.S.

    17 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211240

    FDA
    17 Feb 2022
    Share Share
    Solaris Pharma's Generic Clindamycin and Tretinoin Receives Approval in the U.S.
    Solaris Pharma's Generic Clindamycin and Tretinoin Receives Approval in the U.S.

    10 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212845

    FDA
    10 Feb 2022
    Share Share
    Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal®
    Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal®

    27 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/27/2321700/0/en/Solaris-Pharma-Receives-FDA-Approval-for-Generic-Metrogel-Vaginal.html

    GLOBENEWSWIRE
    27 Oct 2021
    Share Share
    Solaris Pharma’s Generics Metronidazole Receives Approvals In US
    Solaris Pharma’s Generics Metronidazole Receives Approvals In US

    19 Oct 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213648

    FDA
    19 Oct 2021
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search